|
BCL-10 (B Cell Lymphoma 10)
|
P2011-01 |
$294.80
|
|
|
BCL-10 (B Cell Lymphoma 10)
|
P2011-02 |
$587.40
|
|
|
BRCA1 (Tumor Suppressor Protein and Transcription Factor)
|
P2005-01 |
$341.00
|
|
|
BRCA1 (Tumor Suppressor Protein and Transcription Factor)
|
P2005-02 |
$682.00
|
|
|
c-fos (proto oncogene)
|
P2013-01 |
$283.80
|
|
|
c-fos (proto oncogene)
|
P2013-02 |
$566.50
|
|
|
c-jun (proto oncogene) (12.5 ug)
|
P2014-02 |
$566.50
|
|
|
c-jun (proto oncogene) (5 ug)
|
P2014-01 |
$283.80
|
|
|
c-myc (proto oncogene) (12.5 ug)
|
P2015-02 |
$566.50
|
|
|
c-myc (proto oncogene) (5 ug)
|
P2015-01 |
$283.80
|
|
|
CSK (c-src Tyrosine Kinase)
|
R5025-01 |
$283.80
|
|
|
ERK2
|
P5056-01 |
$283.80
|
|
|
ERK2
|
P5056-02 |
$566.50
|
|
|
FGF-1 (acidic fibroblast growth factor)
|
P2017-01 |
$260.70
|
|
|
FGF-1 (acidic fibroblast growth factor)
|
P2017-02 |
$520.30
|
|
|
FGF-2 (basic fibroblast growth factor)
|
P2018-01 |
$260.70
|
|
|
FGF-2 (basic fibroblast growth factor)
|
P2018-02 |
$520.30
|
|
|
FRA-1 (Fos-related antigen 1)
|
P2020-01 |
$260.70
|
|
|
FRA-1 (Fos-related antigen 1)
|
P2020-02 |
$520.30
|
|
|
HIF-1a CTAD [776-826] (Hypoxia-Inducible Factor 1^ alpha^ C-term
|
P2025-01 |
$258.50
|
|
